Mallinckrodt plc to report second quarter results on may 8, 2014
Dublin--(business wire)--mallinckrodt plc (nyse: mnk) will report second quarter results on thursday, may 8, 2014. the company will hold a conference call for investors from 7:30-8:00am, u.s. eastern time. shortly after the earnings call, the company will hold a separate “live” fireside chat question and answer session for investors at the st. regis new york, 2 east 55th street at 5th avenue in new york city, which will also be available by conference call. those wishing to attend the fireside chat may arrive at the st. regis at 7:30am and proceed to the st. regis roof meeting room, where questions will be taken both live and by phone beginning at 8:15am. the calls can be accessed in three ways. at the mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx by telephone: for both “listen-only” participants and those who wish to take part in the question-and-answer portion of the second session, the telephone dial-in number in the u.s. (877) 359-9508. for participants outside the u.s., the dial-in number is (224) 357-2393. the conference i.d. (access number) for the earnings call at 7:30am is 30870215 and the i.d. for the fireside chat is 32627753 through an audio replay: a replay of the call will be available by 4pm u.s. eastern time on may 8, 2014, and ending at 11:59pm/ u.s. eastern time on may 15, 2014. the dial-in number for u.s. participants is (855) 859-2056. for participants outside the u.s., the replay dial-in number is (404) 537-3406. the replay conference i.d. for the earnings call is 30870215 and the conference i.d. to hear the fireside chat is 32627753 those who listen to the earnings call or webcast will need to call back to the same number noted above to participate in the fireside chat. please note the two segments have separate conference i.d. numbers. if you wish to join the live fireside chat at the st. regis new york, please rsvp to investor.relations@mallinckrodt.com to ensure you are registered. about mallinckrodt: mallinckrodt is a global specialty pharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. the company’s core strengths include the acquisition and management of highly regulated raw materials; deep regulatory expertise; and specialized chemistry, formulation and manufacturing capabilities. the company’s specialty pharmaceuticals segment includes branded and specialty generic drugs and active pharmaceutical ingredients, and the global medical imaging segment includes contrast media and nuclear imaging agents. mallinckrodt has approximately 5,500 employees worldwide and a commercial presence in approximately 65 countries. the company’s fiscal 2013 revenue totaled $2.2 billion. to learn more about mallinckrodt, visit www.mallinckrodt.com.
MNK Ratings Summary
MNK Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission